Results 81 to 90 of about 1,013,993 (235)

Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe [PDF]

open access: yesEmerging Infectious Diseases, 2020
Early infections with severe acute respiratory syndrome coronavirus 2 in Europe were detected in travelers from Wuhan, China, in January 2020. In 1 tour group, 5 of 30 members were ill; 3 cases were laboratory confirmed. In addition, a healthcare worker was infected. This event documents early importation and subsequent spread of the virus in Europe.
Alexis Ardoin   +12 more
openaire   +4 more sources

Urticaria in an infant with SARS-CoV-2 positivity [PDF]

open access: yes, 2020
Last months have been marked by the global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the coronavirus disease 19 (COVID-19 ...
Balduzzi V   +10 more
core   +1 more source

COVID-19 Treatment in Medan, Indonesia: A Case Report [PDF]

open access: yes, 2021
In the past decades, two known zoonotic coronaviruses, SARS-CoV and MERS-CoV, have been reported to damage the respiratory tract and cause severe outbreaks.
Fadinie, Wulan
core   +2 more sources

Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation [PDF]

open access: yesJournal of Infection, 2020
Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. However, limited data was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reactivation.
Ye, Guangming   +7 more
openaire   +3 more sources

Severe reinfection with severe acute respiratory syndrome coronavirus 2 in a nursing home resident: a case report

open access: yesJournal of Medical Case Reports, 2021
Background The topic of natural immunity related to severe acute respiratory syndrome coronavirus 2 remains controversial. Although evidence suggests postinfection immunity can be achieved, there have been reported cases of reinfection with similar or ...
Nimrah Bader   +2 more
doaj   +1 more source

Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past [PDF]

open access: yes, 2020
© 2020 Elsevier B.V. Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in China and rapidly spread worldwide.
Gianni, P., Giannis, D., Ziogas, I. A.
core   +2 more sources

Fungal Infections Complicating COVID-19 [PDF]

open access: yes, 2022
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions.

core   +1 more source

Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019

open access: yesCurrent Opinion in Allergy & Clinical Immunology, 2021
Purpose of review In December 2019, a novel respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described and named coronavirus disease 2019 (COVID-19). Although the knowledge base surrounding COVID-19 and SARS-CoV-2 has grown rapidly, significant gaps in our knowledge remain and
Timberlake, Dylan T.   +2 more
openaire   +3 more sources

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global health.
Luis Ortega‐Paz   +3 more
doaj   +1 more source

Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses? [PDF]

open access: yes
Recent reports indicated that myelin oligodendrocyte glycoprotein antibody-associated disease might be a rare complication after severe acute respiratory syndrome coronavirus 2 infection or vaccination.
Bauer, Angelika   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy